Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Jim Lamb who wrote (812)	3/30/1998 1:42:00 PM
From: Jerry Olson	Read Replies (1) \| Respond to of 9523

Just some INFO for the thread<g>...only the begining.....:>} Monday March 30, 1:24 pm Eastern Time RESEARCH ALERT-View on Pfizer's Viagra rises CHICAGO, March 30 (Reuters) - NationsBanc Montgomery Securities drug industry analyst Leonard Yaffe said Monday he plans to raise his 1998 sales estimate for Viagra, a new impotency drug from Pfizer Inc., to $400 million from $275 million. Shares in New York-based Pfizer were up 1-3/4 to 97-1/8 in midday New York Stock Exchange trading. Viagra was approved for U.S. marketing on Friday, setting up a mid-April U.S. market launch, earlier than Yaffe said he had expected. For 1999, Yaffe said he estimates Viagra sales of $800 million. ''We think this could be the first $6-billion drug,'' he said. More Quotes and News: Pfizer Inc (NYSE:PFE - news) Related News Categories: US Market News, health Help Copyright c 1998 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon See our Important Disclaimers and Legal Information. Questions or Comments?